TABLE 4.
Antigen position | Peptide sequence | Mutation | No. of patients | Variant frequency (%)b |
---|---|---|---|---|
VP1 antigen | ||||
BKV VP1 p62 | NLRGFSLKL | F66L | 1 | 1.87 |
BKV VP1 p84 | KMLPCYSTA | L86P | 1 | 1.87 |
BKV VP1 p108 | LLMWEAVTV | E112G | 1 | 2.38 |
BKV VP1 p128 | NLHAGSQKV | L129F | 1 | 1.72 |
Q134P | 1 | 4.49 | ||
K135Q | 1 | 5.34 | ||
BKV VP1 p245 | LLDEQGVGPL | L254F | 1 | 1.67 |
BKV VP1 p259 | SLYVSAADI | L260P | 1 | 3.62 |
Large T antigen | ||||
BKV T p157 | TLACFAVYT | V163A | 1 | 3.03 |
BKV T p176 | KLMEKYSVT | M178I | 3 | 2.26; 2.30; 3.53 |
E179G | 2 | 2.25; 2.27 | ||
K180N | 5 | 1.92; 2.34; 2.34; 2.49; 3.27 | ||
BKV T p199 | FLTPHRHRV | H203R | 1 | 1.96 |
BKV T p216 | KLCTFSFLI | K216R | 1 | 1.88 |
C218R | 1 | 1.79 | ||
T219A | 1 | 1.93 | ||
T219N | 1 | 2.39 | ||
F220L | 1 | 4.03 | ||
S221R | 1 | 3.31 | ||
S221C | 1 | 3.3 | ||
S221N | 1 | 3.18 | ||
I224F | 2 | 2.00; 2.37 | ||
BKV T p313 | PYHFKYHEKHFANAT | K321E | 1 | 2.04 |
T327N | 1 | 1.97 | ||
BKV T p362 | MLTERFNHIL | T364A | 1 | 1.94 |
F367S | 2 | 1.98; 3.22 | ||
BKV T p395 | WLHCLLPKM | H397R | 1 | 2.07 |
BKV T p398 | CLLPKMDSV | S405F | 1 | 4.02 |
BKV T p406 | VIFDFLHCI | D409E | 3 | 1.44; 1.65; 2.21 |
D409G | 2 | 1.56; 2.61 | ||
D409Y | 2 | 1.55; 2.74 | ||
BKV T p410 | FLHCIVFNV | L411S | 1 | 4.03 |
BKV T p558 | SLQNSEFLL | N561T | 1 | 2.1 |
S562P | 1 | 3.36 | ||
BKV T p570 | ILQSGMTLL | I570F | 2 | 2.05; 2.19 |
Small T antigen | ||||
BKV T p4 | VLNREESME | R7G | 1 | 1.8 |
BKV T p10 | SMELMDLLGL | E12V | 1 | 9.28 |
BKV T p125 | FLRKEPLVWI | R127G | 2 | 1.51; 1.86 |
K128R | 1 | 1.85 |
Low-level variants of BKV HLA-B0702- and HLA-B08-restricted peptide sequences were not identified.
Variants that appeared in multiple specimens for a patient were averaged. Frequencies for each patient are listed.